Summary:Late complications occurring after allogeneic bone marrow transplant (BMT) are increasingly reported, since more patients survive. Among these late complications, solid tumors are of particular clinical concern. Only malignant brain tumors have been reported (astrocytoma, glioblastoma). We describe two cases of meningiomas developing 13 and 15 years after the graft. Occurrence of such benign tumors has been described after treatment of ALL, but not following allogeneic BMT. It is important to consider the diagnosis of meningioma in long-term survivors presenting with neurological symptoms. Keywords: ALL; AML; ABMT meningioma Among the late effects that have been described after allogeneic BMT, solid tumors are of particular concern as an increasing number of patients survive the early phase after transplantation and remain free of their original disease. 1 Among solid tumors, several cases of malignant brain tumors have been described but no benign tumors. [2][3][4] We report here two cases of cranial meningiomas developing 13 and 15 years after allogeneic BMT for AML and ALL.
Case reports
Case 1In 1982, a 24-year-old patient with AML was in first complete remission after treatment with cytarabine, rubidomycin, doxorubicin and thioguanine as induction therapy, followed by 3 weekly courses of cytarabine and thioguanine. He then underwent BMT from an HLA-identical sibling donor. Conditioning comprised cyclophosphamide (60-mg/kg J1-2) and total body irradiation (10 Gy, in a single fraction). He remained well until 1995, when he experi- enced two episodes of temporal lobe epilepsy. A CT scan showed a left frontotemporal tumor and a diagnosis of meningioma was made by stereotactic biopsy. Histological studies confirmed the diagnosis of meningotheliomatous meningioma but showed necrosis and many atypical features. There were many cytogenetic abnormalities (monosomy 22, 10, 15, trisomy 5, del (11q14), del (2p12), 1qh+). The patient is now well on antiepileptic treatment.
Case 2In 1980, a 17-month-old patient was diagnosed with standard risk B cell ALL. As part of the ongoing protocol (12 LA 80), he received total brain irradiation of 24 Gy as central nervous system (CNS) prophylaxis. Treatment was discontinued in 1984, while the patient was in complete remission. He presented with a medullary and testicular relapse 1 year later and was treated with chemotherapy again (RALL 84 protocol) and testicular irradiation (10 Gy in a single fraction). He then underwent allogeneic BMT from an HLA-identical sibling donor while in second complete remission. Conditioning comprised chemotherapy (VP 16, cytarabine and cyclophosphamide) and total body irradiation (10 Gy, in a single dose). In 1995, a CT scan was performed because of left exopthalmus and oculomotor paralysis (third cranial nerve). It showed an intraocular and intracavernous lesion associated with many hypodensities in the brain. A diagnosis of meningotheliomatous meningioma was made on biopsy. As the tumor increased rapidly in size, it was surgically removed, al...